pyrimethamine has been researched along with pamaquine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishikawa, M; Ogino, T; Ohta, T; Ono-Ogata, T; Yamagata, H | 1 |
| Bork, S; Claveria, FG; Fujisaki, K; Hirata, H; Igarashi, I; Matsuo, T; Nagai, A; Xuan, X; Yokoyama, N; Zhu, Y | 1 |
| Baresel, PC; Campo, B; Magill, AJ; Ohrt, C; Rochford, R; Sampath, A; Tekwani, BL; Walker, LA | 1 |
3 other study(ies) available for pyrimethamine and pamaquine
| Article | Year |
|---|---|
Mutagenic activity and mutational specificity of antiprotozoal drugs with and without nitrite treatment.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Escherichia coli; Mutagenicity Tests; Mutagens; Mutation; Nitrites; Primaquine; Pyrimethamine; Pyrimidines; Rats; Salmonella typhimurium; Trimethoprim | 2002 |
Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures.
Topics: Aminoquinolines; Animals; Antimalarials; Artemisinins; Artesunate; Babesia; Cells, Cultured; Dose-Response Relationship, Drug; Pyrimethamine; Sesquiterpenes | 2003 |
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Topics: Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Doxycycline; Drug Evaluation, Preclinical; Erythrocyte Count; Erythrocyte Transfusion; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Mefloquine; Mice; Mice, Inbred NOD; Mice, SCID; Primaquine; Pyrimethamine; Reproducibility of Results; Sensitivity and Specificity; Transplantation, Heterologous | 2013 |